Zura Bio Limited
ZURA
$1.37
$0.1411.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.18% | 32.61% | 44.69% | -96.02% | -145.06% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -45.23% | -61.75% | -79.49% | 72.33% | 107.87% |
| Change in Net Operating Assets | -54.91% | -3.66% | 153.66% | 14.29% | 27.98% |
| Cash from Operations | -86.50% | -98.75% | -99.65% | -293.66% | -1,058.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.50% | 68.93% | 47.62% | -60.67% | 24.46% |
| Cash from Investing | 36.56% | 68.74% | 47.50% | -22.81% | 38.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -43.50% | -43.50% | -48.25% | 12.81% | -- |
| Repurchase of Common Stock | -1,345.45% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 293.08% | 434.72% | 231.09% | 384.48% | 446.00% |
| Cash from Financing | -9.44% | -13.36% | -23.11% | 33.25% | 652.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.93% | -16.43% | -30.31% | 16.42% | 12,311.19% |